Population Pharmacokinetics of Magnesium Sulfate in Preeclampsia and Associated Factors
Abstract Background and Objective The pharmacokinetic basis of magnesium sulphate (MgSO4) dosing regimens for preeclampsia (PE) prophylaxis and treatment is not clearly established. The aim of study is to develop a population pharmacokinetic (PK) model of MgSO4 in PE, and to determine key covariates...
Saved in:
Main Authors: | Tatiana Xavier da Costa (Author), Francine Johansson Azeredo (Author), Marcela Abbott Galvão Ururahy (Author), Miguel Adelino da Silva Filho (Author), Rand Randall Martins (Author), Antonio Gouveia Oliveira (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population pharmacokinetics and dose optimization of magnesium sulfate in Chinese preeclampsia population
by: Jing Deng, et al.
Published: (2024) -
Anticonvulsant for preeclampsia: Magnesium sulfate or Diazepam ?
by: Joserizal Serudji
Published: (2022) -
Magnesium intoxication in women with preeclampsia with severe features treated with magnesium sulfate
by: Muhammad Ilham Aldika Akbar, et al.
Published: (2020) -
Shortened Postpartum Magnesium Sulfate Treatment for Severe Preeclampsia
by: Jiraphol Kumpalum, et al.
Published: (2010) -
Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsiaAJOG Global Reports at a Glance
by: Kathleen Brookfield, MD, PhD, MPH, et al.
Published: (2021)